This is an interesting and potentially also clinically relevant finding considering the bad prognostic effect of high numbers of TAM in cHL (51, 52), which might thus be counterbalanced by PDL1 inhibition. This evidence concerns the gene CD274 and classic Hodgkin lymphoma.